A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 18, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Oct 23, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the TXN SEC filings page.
Texas Instruments Incorporated (TXN) reported $20.8B in revenue over the twelve months to Sep 30, 2026, up 20.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Texas Instruments converts profits to cash, but its capital-heavy model makes recovery depend on controlling factory investment.
In FY2025, operating cash flow rose13.2% while net income rose only4.2% , showing cash recovery outpaced accounting earnings. Free cash flow rose73.8% as capital expenditures fell5.6% , indicating that investment moderation—not just improved operations—drove much of the cash improvement.
Revenue grew
Free cash flow of
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Texas Instruments Incorporated's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Texas Instruments Incorporated scores 90/100 on it among other operating companies.
Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Texas Instruments Incorporated scores 32/100 on it among other operating companies.
Texas Instruments Incorporated's net debt of $10.3B, being $13.5B of long-term debt less $3.2B of cash, came to 1.30 times its EBITDA in fiscal year 2025. Operating companies are ranked here on long-term debt less cash against their EBITDA, where a lower multiple is the safer one, and Texas Instruments Incorporated scores 55/100 among other operating companies measured the same way.
Texas Instruments Incorporated held $4.35 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 4.35. Liquidity ranks operating companies on that ratio, and Texas Instruments Incorporated scores 89/100 among other operating companies.
Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Texas Instruments Incorporated scores 70/100 on it among other operating companies.
Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. Texas Instruments Incorporated scores 81/100 on it among other operating companies.
Texas Instruments Incorporated scores 12.32, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $267.2B against total liabilities of $18.3B. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Texas Instruments Incorporated passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.
For every $1 of reported earnings, Texas Instruments Incorporated generates $1.43 in operating cash flow ($7.2B OCF vs $5.0B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Texas Instruments Incorporated earns $11.09 in operating income for every $1 of interest expense ($6.0B vs $543.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Texas Instruments Incorporated generated $6.1B in revenue in Q3 2026. This represents an increase of 27.7% from the same quarter a year earlier. Against the prior quarter it is up 10.8%.
Texas Instruments Incorporated's EBITDA was $3.5B in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 58.3% from the same quarter a year earlier. Against the prior quarter it is up 20.8%.
Texas Instruments Incorporated reported $2.4B in net income in Q3 2026. This represents an increase of 77.8% from the same quarter a year earlier. Against the prior quarter it is up 22.5%.
Texas Instruments Incorporated earned $2.62 per diluted share (EPS) in Q3 2026. This represents an increase of 77.0% from the same quarter a year earlier. Against the prior quarter it is up 22.4%.
Cash & Balance Sheet
Texas Instruments Incorporated generated $3.0B in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 197.7% from the same quarter a year earlier. Against the prior quarter it is up 35.0%.
Texas Instruments Incorporated held $4.2B in cash against $12.9B in long-term debt as of Q3 2026.
Texas Instruments Incorporated paid $1.42 per share in dividends in Q3 2026. This represents an increase of 4.4% from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
Texas Instruments Incorporated's gross margin was 64.2% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 6.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.8 percentage points.
Texas Instruments Incorporated's operating margin was 47.5% in Q3 2026, reflecting core business profitability. This is up 12.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.2 percentage points.
Texas Instruments Incorporated's net profit margin was 40.1% in Q3 2026, showing the share of revenue converted to profit. This is up 11.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.8 percentage points.
Texas Instruments Incorporated's quarterly ROE was 12.6% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 4.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.6 percentage points.
Capital Allocation
Texas Instruments Incorporated invested $530.0M in research and development in Q3 2026. This represents an increase of 2.3% from the same quarter a year earlier. Against the prior quarter it is down 0.9%.
Texas Instruments Incorporated spent $48.0M on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 59.7% from the same quarter a year earlier. Against the prior quarter it is up 77.8%.
Texas Instruments Incorporated invested $463.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 61.3% from the same quarter a year earlier. Against the prior quarter it is down 9.9%.
TXN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.1B+27.7% | $5.5B+22.8% | $4.8B+18.6% | $4.4B+10.4% | $4.7B+14.2% | $4.4B+16.4% | $4.1B+11.1% | $4.0B-1.7% |
| Cost of Revenue | $2.2B+7.4% | $2.1B+12.7% | $2.0B+15.4% | $2.0B+15.2% | $2.0B+20.4% | $1.9B+16.3% | $1.8B+12.1% | $1.7B+2.9% |
| Gross Profit | $3.9B+42.7% | $3.4B+30.2% | $2.8B+21.0% | $2.5B+6.8% | $2.7B+10.1% | $2.6B+16.5% | $2.3B+10.4% | $2.3B-4.8% |
| R&D Expenses | $530.0M+2.3% | $535.0M+1.5% | $510.0M-1.4% | $521.0M+6.1% | $518.0M+5.3% | $527.0M+5.8% | $517.0M+8.2% | $491.0M+6.7% |
| SG&A Expenses | $476.0M+4.2% | $490.0M+1.0% | $464.0M-1.7% | $446.0M0.0% | $457.0M+6.8% | $485.0M+4.3% | $472.0M+3.7% | $446.0M+1.8% |
| Operating Income | $2.9B+72.8% | $2.3B+47.8% | $1.8B+36.6% | $1.5B+7.0% | $1.7B+7.0% | $1.6B+25.2% | $1.3B+3.0% | $1.4B-10.2% |
| EBITDA | $3.5B+58.3% | $2.9B+41.2% | $2.3B+34.4% | $2.0B+12.1% | $2.2B+12.5% | $2.0B+25.6% | $1.7B+7.1% | $1.8B-3.3% |
| Interest Expense | $141.0M0.0% | $141.0M+6.0% | $141.0M+10.2% | $141.0M+8.5% | $141.0M+7.6% | $133.0M+1.5% | $128.0M+10.3% | $130.0M+32.7% |
| Income Tax | $380.0M+72.7% | $258.0M+41.0% | $169.0M+74.2% | $209.0M+35.7% | $220.0M+14.6% | $183.0M+52.5% | $97.0M-48.4% | $154.0M-13.0% |
| Net Income | $2.4B+77.8% | $2.0B+52.9% | $1.5B+31.0% | $1.2B-3.5% | $1.4B+0.1% | $1.3B+14.9% | $1.2B+6.7% | $1.2B-12.1% |
| EPS (Basic) | $2.64+77.2% | $2.16+52.1% | $1.69+31.0% | $1.27-3.8% | $1.49+0.7% | $1.42+15.4% | $1.29+6.6% | $1.32-12.0% |
| EPS (Diluted) | $2.62+77.0% | $2.14+51.8% | $1.68+31.2% | $1.27-3.1% | $1.48+0.7% | $1.41+15.6% | $1.28+6.7% | $1.31-12.1% |
| Diluted Shares (Avg) | 921M+0.8% | 920M+0.9% | 914M-0.2% | N/A | 914M-0.7% | 912M-0.8% | 916M-0.1% | N/A |
TXN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $36.8B+5.2% | $35.9B+2.7% | $34.4B+1.9% | $34.6B-2.6% | $35.0B-0.9% | $34.9B-0.3% | $33.8B-3.2% | $35.5B+9.8% |
| Current Assets | $16.9B+21.6% | $15.8B+8.8% | $13.8B+5.4% | $13.8B-8.5% | $13.9B-12.6% | $14.5B-13.7% | $13.1B-25.0% | $15.0B-0.6% |
| Cash & Equivalents | $4.2B+27.2% | $3.7B+20.2% | $3.5B+28.4% | $3.2B+0.8% | $3.3B+27.9% | $3.0B+11.1% | $2.8B+11.3% | $3.2B+8.0% |
| Short-Term Investments | $3.9B+109.7% | $3.3B+44.3% | $1.6B-30.7% | $1.7B-62.2% | $1.9B-69.6% | $2.3B-66.7% | $2.2B-71.7% | $4.4B-21.9% |
| Inventory | $4.7B-3.3% | $4.6B-4.3% | $4.7B+0.2% | $4.8B+6.1% | $4.8B+12.4% | $4.8B+17.2% | $4.7B+14.8% | $4.5B+13.2% |
| Accounts Receivable | $2.6B+27.1% | $2.5B+30.3% | $2.2B+20.7% | $2.0B+14.2% | $2.1B+10.7% | $1.9B+13.0% | $1.9B+11.3% | $1.7B-3.8% |
| Long-Term Investments | $15.0M-11.8% | $15.0M-11.8% | $15.0M-25.0% | $16.0M-30.4% | $17.0M-34.6% | $17.0M-37.0% | $20.0M-28.6% | $23.0M-32.4% |
| Goodwill | $4.3B-0.7% | $4.3B-0.7% | $4.3B-0.7% | $4.3B-0.7% | $4.4B0.0% | $4.4B0.0% | $4.4B0.0% | $4.4B0.0% |
| Total Liabilities | $17.7B-3.9% | $17.9B-3.5% | $17.6B+1.5% | $18.3B-1.6% | $18.4B+1.8% | $18.5B+3.9% | $17.4B-3.1% | $18.6B+20.4% |
| Current Liabilities | $3.0B-3.2% | $3.2B+30.2% | $3.1B+24.4% | $3.2B-13.3% | $3.1B-15.4% | $2.5B-31.5% | $2.5B-29.9% | $3.6B+9.7% |
| Non-Current Liabilities | $14.6B-4.1% | $14.6B-8.8% | $14.5B-2.3% | $15.2B+1.3% | $15.3B+6.2% | $16.0B+13.0% | $14.9B+3.6% | $15.0B+23.3% |
| Long-Term Debt | $12.9B-4.7% | $12.9B-8.1% | $12.9B+0.4% | $13.5B+5.5% | $13.5B+5.5% | $14.0B+9.4% | $12.8B+0.1% | $12.8B+20.9% |
| Total Equity | $19.2B+15.4% | $18.0B+9.8% | $16.8B+2.3% | $16.3B-3.7% | $16.6B-3.7% | $16.4B-4.7% | $16.4B-3.4% | $16.9B0.0% |
| Retained Earnings | $54.3B+3.7% | $53.2B+1.7% | $52.5B+0.5% | $52.2B0.0% | $52.4B+0.1% | $52.2B+0.2% | $52.2B0.0% | $52.3B0.0% |
TXN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.4B+56.1% | $2.7B+45.3% | $1.5B+79.0% | $2.3B+12.8% | $2.2B+26.4% | $1.9B+18.4% | $849.0M-16.5% | $2.0B+3.8% |
| Depreciation & Amortization | $576.0M+11.4% | $547.0M+18.9% | $541.0M+27.6% | $537.0M+29.1% | $517.0M+35.0% | $460.0M+26.7% | $424.0M+22.5% | $416.0M+29.2% |
| Stock-Based Compensation | N/A | N/A | $109.0M-6.0% | N/A | N/A | N/A | $116.0M+9.4% | N/A |
| Capital Expenditures | $463.0M-61.3% | $514.0M-60.6% | $676.0M-39.8% | $925.0M-22.4% | $1.2B-9.0% | $1.3B+22.7% | $1.1B-10.0% | $1.2B+3.8% |
| Free Cash Flow | $3.0B+197.7% | $2.2B+294.4% | $844.0Mn/m | $1.3B+64.9% | $993.0M+138.7% | $555.0M+9.5% | -$274.0Mn/m | $806.0M+3.9% |
| Investing Cash Flow | -$987.0Mn/m | -$1.7Bn/m | -$47.0M-103.8% | -$676.0M-210.1% | -$681.0Mn/m | -$1.3Bn/m | $1.3Bn/m | $614.0Mn/m |
| Financing Cash Flow | -$1.9Bn/m | -$890.0Mn/m | -$1.1Bn/m | -$1.7Bn/m | -$1.2Bn/m | -$244.0Mn/m | -$2.5B-238.7% | -$2.0Bn/m |
| Dividends Paid | $1.3B+5.0% | $1.3B+4.9% | $1.3B+4.3% | $1.3B+4.0% | $1.2B+4.1% | $1.2B+4.2% | $1.2B+4.6% | $1.2B+5.0% |
| Share Buybacks | $48.0M-59.7% | $27.0M-91.1% | $158.0M-75.8% | $403.0M-25.0% | $119.0M-62.6% | $302.0M+325.4% | $653.0M+21666.7% | $537.0M+726.2% |
TXN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.2%+6.8pp | 61.4%+3.5pp | 58.0%+1.2pp | 55.9%-1.9pp | 57.4%-2.2pp | 57.9%0.0pp | 56.8%-0.4pp | 57.8%-1.9pp |
| Operating Margin | 47.5%+12.4pp | 42.3%+7.1pp | 37.5%+4.9pp | 33.3%-1.1pp | 35.1%-2.4pp | 35.1%+2.5pp | 32.5%-2.6pp | 34.4%-3.2pp |
| Net Margin | 40.1%+11.3pp | 36.2%+7.1pp | 32.0%+3.0pp | 26.3%-3.8pp | 28.8%-4.0pp | 29.1%-0.4pp | 29.0%-1.2pp | 30.1%-3.6pp |
| Return on Equity | 12.6%+4.4pp | 11.0%+3.1pp | 9.2%+2.0pp | 7.1%0.0pp | 8.2%+0.3pp | 7.9%+1.3pp | 7.2%+0.7pp | 7.1%-1.0pp |
| Return on Assets | 6.6%+2.7pp | 5.5%+1.8pp | 4.5%+1.0pp | 3.4%0.0pp | 3.9%0.0pp | 3.7%+0.5pp | 3.5%+0.3pp | 3.4%-0.9pp |
| Current Ratio | 5.60+1.1x | 4.86-1.0x | 4.46-0.8x | 4.35+0.2x | 4.45+0.1x | 5.81+1.2x | 5.26+0.3x | 4.12-0.4x |
| Debt-to-Equity | 0.67-0.1x | 0.72-0.1x | 0.770.0x | 0.83+0.1x | 0.81+0.1x | 0.86+0.1x | 0.780.0x | 0.76+0.1x |
| Liabilities-to-Equity | 0.92-0.2x | 0.99-0.1x | 1.050.0x | 1.130.0x | 1.11+0.1x | 1.13+0.1x | 1.060.0x | 1.10+0.2x |
| Asset Turnover | 0.160.0x | 0.150.0x | 0.140.0x | 0.130.0x | 0.140.0x | 0.130.0x | 0.120.0x | 0.110.0x |
| FCF Margin | 48.8%+27.9pp | 40.1%+27.6pp | 17.5%+24.2pp | 30.0%+9.9pp | 20.9%+10.9pp | 12.5%-0.8pp | -6.7%-0.4pp | 20.1%+1.1pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Texas Instruments Incorporated TXN | FY2025 | $17.7B | $5.0B | 28.3% | $267.2B | 70/100 |
| Intel Corp INTC | FY2025 | $52.9B | -$267.0M | -0.5% | $296.2B | 26/100 |
| Arm Holdings ARM | FY2026 | $4.9B | $904.0M | 18.4% | $189.6B | 77/100 |
| Advanced Micro Devices AMD | FY2025 | $34.6B | $4.3B | 12.5% | $809.6B | 68/100 |
| Analog Devices, Inc. ADI | FY2025 | $11.0B | $2.3B | 20.6% | $182.9B | 64/100 |
| Qualcomm Inc QCOM | FY2026 | $43.1B | $13.6B | 31.6% | $171.0B | 71/100 |
Where Texas Instruments Incorporated Ranks
Frequently Asked Questions
Texas Instruments Incorporated (TXN) reported $17.7B in total revenue for fiscal year 2025. This represents a 13.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Texas Instruments Incorporated (TXN) revenue grew by 13.0% year-over-year, from $15.6B to $17.7B in fiscal year 2025.
Yes, Texas Instruments Incorporated (TXN) reported a net income of $7.1B over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $5.0B, with a net profit margin of 28.3%.
Texas Instruments Incorporated (TXN) had EBITDA of $7.9B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, Texas Instruments Incorporated (TXN) had $3.2B in cash and equivalents against $13.5B in long-term debt.
Texas Instruments Incorporated (TXN) had a gross margin of 57.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Texas Instruments Incorporated (TXN) had an operating margin of 34.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
Texas Instruments Incorporated (TXN) had a net profit margin of 28.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Yes, Texas Instruments Incorporated (TXN) paid $5.50 per share in dividends during fiscal year 2025.
Texas Instruments Incorporated (TXN) has a return on equity of 30.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Texas Instruments Incorporated (TXN) generated $2.6B in free cash flow during fiscal year 2025. This represents a 73.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Texas Instruments Incorporated (TXN) generated $7.2B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
Texas Instruments Incorporated (TXN) had $34.6B in total assets as of fiscal year 2025, including both current and long-term assets.
Texas Instruments Incorporated (TXN) invested $4.5B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Texas Instruments Incorporated (TXN) invested $2.1B in research and development during fiscal year 2025.
Texas Instruments Incorporated (TXN) had a current ratio of 4.35 as of fiscal year 2025, which is generally considered healthy.
Texas Instruments Incorporated (TXN) had a debt-to-equity ratio of 0.83 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Texas Instruments Incorporated (TXN) had a liabilities-to-equity ratio of 1.13 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Texas Instruments Incorporated (TXN) had a return on assets of 14.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Texas Instruments Incorporated (TXN) trades at 37.6x earnings, its market capitalization divided by $7.1B net income, trailing 12 months to September 30, 2026. The market capitalization is $267.2B as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Texas Instruments Incorporated (TXN) trades at 12.9x sales, its market capitalization divided by $20.8B revenue, trailing 12 months to September 30, 2026. The market capitalization is $267.2B as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Texas Instruments Incorporated (TXN) has an Altman Z-Score of 12.32, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Texas Instruments Incorporated (TXN) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Texas Instruments Incorporated (TXN) has an earnings quality ratio of 1.43x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Texas Instruments Incorporated (TXN) has an interest coverage ratio of 11.09x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
Texas Instruments Incorporated (TXN) scores 70 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.